Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — BRUKER CORP

Accession: 0001193125-26-449782

Filed: 2026-11-05

Period: 2026-11-05

CIK: 0001109354

SIC: 3826 (LABORATORY ANALYTICAL INSTRUMENTS)

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — brkr-20261105.htm (Primary)

EX-99.1 (brkr-ex99_1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: brkr-20261105.htm · Sequence: 1

8-K

0001109354false00011093542026-11-052026-11-050001109354us-gaap:CommonStockMember2026-11-052026-11-050001109354brkr:SixPointThreeSevenFivePercentageMandatoryConvertiblePreferredStockSeriesAMember2026-11-052026-11-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 5, 2026

BRUKER CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

000-30833

04-3110160

(State or other jurisdiction of

(Commission

(I.R.S. Employer

incorporation)

File number)

Identification No.)

40 Manning Road

Billerica, MA 01821

(Address of principal executive offices) (Zip Code)

(978) 663-3660

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which Registered

Common Stock, $0.01 par value per share

BRKR

The Nasdaq Global Select Market

6.375% Mandatory Convertible Preferred Stock, Series A, $0.01 par value per share

BRKRP

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

As previously announced, effective July 1, 2026 (the “Effective Date”), Bruker Corporation (the “Company”) completed a reorganization of its reportable segments to streamline its organizational structure and further facilitate decision making, accountability, customer focus, and innovation. Prior to the Effective Date, the Company had the following four reportable segments: (i) Bruker Scientific Instruments (“BSI”) BioSpin, (ii) BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection), (iii) BSI NANO, and (iv) Bruker Energy & Supercon Technologies (“BEST”).

As a result of this reorganization, as of the Effective Date, the Company’s reportable segments consist of the following four reportable segments:

•

BSI BIOS, consisting of:

o

The BioSpin division, which combines the former Magnetic Resonance Spectroscopy, Preclinical Imaging, Biopharma and Applied Services, and Services and Lifecycle Support divisions, all of which were previously part of the former BSI BioSpin segment;

o

The SciY (formerly Integrated Data Solutions) division, previously part of the former BSI BioSpin segment;

o

The Chemspeed Technologies (“CST”) (formerly Automation) division, previously part of the former BSI BioSpin segment;

o

The Daltonics division (formerly Bruker Life Sciences Mass Spectrometry and Bruker Applied Mass Spectrometry), previously part of the former BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection) segment;

o

The Optics division, previously part of the former BSI CALID segment; and

o

The Mimetas division, a new division formed during the third quarter of 2026 following the acquisition of a majority interest in Mimetas B.V.

•

BSI Microbiology and Infection Diagnostics (“BMID”), consisting of the Microbiology, Molecular Diagnostics, and Biomedical Systems divisions, which were previously part of the former BSI CALID segment.

•

BSI NANO, for which no changes were made to the reportable segment structure in connection with the reorganization.

•

BEST, for which no changes were made to the reportable segment structure in connection with the reorganization.

For information purposes and to provide investors with historical information on a basis consistent with its new reporting structure, the Company has provided recast reportable segment information that conforms to the new reporting structure. This reportable operating segment realignment did not impact the Company’s historical consolidated results of operations, financial position or cash flows.

Attached as Exhibit 99.1 and incorporated by reference in this Item 8.01 are schedules containing recast reportable segment information for the years ended December 31, 2025 and 2024, the three months ended March 31, 2025 and 2026, the three and six months ended June 30, 2025 and 2026, and the three and nine months ended September 30, 2025. The recast information has been derived from, and should be read in conjunction with, the Company's previously filed Annual Reports on Form 10-K for the years ended December 31, 2025 and 2024, and Quarterly Reports on Form 10-Q for the periods ended March 31, 2025 and 2026, June 30, 2025 and 2026, and September 30, 2025, in which the corresponding financial information was originally reported.

As noted above, the segment changes and supplemental disclosures discussed above have no impact on the Company’s historical consolidated results of operations, financial position or cash flows. The recast financial information contained in Exhibit 99.1 does not represent a restatement of the Company’s previously issued financial statements.

Section 9 – Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits.

Number

Description

99.1

Recast segment information of Bruker Corporation

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BRUKER CORPORATION

(Registrant)

Date: November 5, 2026

By:

/s/ THOMAS M. BURES

Thomas M. Bures

Chief Accounting Officer

EX-99.1

EX-99.1

Filename: brkr-ex99_1.htm · Sequence: 2

EX-99.1

Exhibit 99.1

As Reported

As Recast

Bruker Scientific Instruments ("BSI") BioSpin

BSI Chemicals, Applied Markets, Life Sciences, In Vitro Diagnostics, Detection ("BSI CALID")

BSI NANO

Bruker Energy & Supercon Technologies ("BEST")

Corporate

Total

BSI Biosystems ("BIOS")

BSI Microbiology and Infection Diagnostics ("BMID")

BSI NANO

BEST

Corporate

Total

Three months ended March 31, 2026

Revenue from external customers

$

197.5

$

316.3

$

246.0

$

63.6

—

$

823.4

$

381.5

$

132.3

$

246.0

$

63.6

—

$

823.4

Intersegment revenue

—

—

—

3.2

—

3.2

—

—

—

$

3.2

—

3.2

Total segment revenue

$

197.5

$

316.3

$

246.0

$

66.8

—

$

826.6

$

381.5

$

132.3

$

246.0

$

66.8

—

$

826.6

Gross profit

$

88.9

$

167.7

$

109.1

$

14.1

—

$

379.8

$

178.7

$

77.9

$

109.1

$

14.1

—

$

379.8

Gross profit margin

45.0

%

53.0

%

44.3

%

21.1

%

—

46.1

%

46.8

%

58.9

%

44.3

%

21.1

%

—

46.1

%

Operating income

$

16.0

$

40.7

$

(21.8

)

$

7.5

$

(32.2

)

$

10.2

$

27.4

$

29.3

$

(21.8

)

$

7.5

$

(32.2

)

$

10.2

Operating margin

8.1

%

12.9

%

(8.9

)%

11.2

%

—

1.2

%

7.2

%

22.1

%

(8.9

)%

11.2

%

—

1.2

%

As Reported

As Recast

BSI BioSpin

BSI CALID

BSI NANO

BEST

Corporate

Total

BSI BIOS

BSI BMID

BSI NANO

BEST

Corporate

Total

Three months ended June 30, 2026

Revenue from external customers

$

195.7

$

310.3

$

261.3

$

71.2

—

$

838.5

$

376.1

$

129.9

$

261.3

$

71.2

—

$

838.5

Intersegment revenue

—

—

—

3.0

—

3.0

—

—

—

3.0

—

3.0

Total segment revenue

$

195.7

$

310.3

$

261.3

$

74.2

—

$

841.5

$

376.1

$

129.9

$

261.3

$

74.2

—

$

841.5

Gross profit

$

98.8

$

172.6

$

131.4

$

13.2

—

$

416.0

$

194.8

$

76.6

$

131.4

$

13.2

—

$

416.0

Gross profit margin

50.5

%

55.6

%

50.3

%

17.8

%

—

49.6

%

51.8

%

59.0

%

50.3

%

17.8

%

—

49.6

%

Operating income

$

(64.6

)

$

48.3

$

(20.9

)

$

7.5

$

(35.6

)

$

(65.3

)

$

(45.8

)

$

29.5

$

(20.9

)

$

7.5

$

(35.6

)

$

(65.3

)

Operating margin

(33.0

)%

15.6

%

(8.0

)%

10.1

%

—

(7.8

)%

(12.2

)%

22.7

%

(8.0

)%

10.1

%

—

(7.8

)%

Six months ended June 30, 2026

Revenue from external customers

$

393.2

$

626.6

$

507.3

$

134.8

—

$

1,661.9

$

757.6

$

262.2

$

507.3

$

134.8

—

$

1,661.9

Intersegment revenue

—

—

—

6.2

—

6.2

—

—

—

6.2

—

6.2

Total segment revenue

$

393.2

$

626.6

$

507.3

$

141.0

—

$

1,668.1

$

757.6

$

262.2

$

507.3

$

141.0

—

$

1,668.1

Gross profit

$

187.6

$

340.3

$

240.5

$

27.4

—

$

795.8

$

373.4

$

154.5

$

240.5

$

27.4

—

$

795.8

Gross profit margin

47.7

%

54.3

%

47.4

%

19.4

%

—

47.9

%

49.3

%

58.9

%

47.4

%

19.4

%

—

47.9

%

Operating income

$

(48.6

)

$

89.0

$

(42.7

)

$

15.0

$

(67.8

)

$

(55.1

)

$

(18.4

)

$

58.8

$

(42.7

)

$

15.0

$

(67.8

)

$

(55.1

)

Operating margin

(12.4

)%

14.2

%

(8.4

)%

10.6

%

—

(3.3

)%

(2.4

)%

22.4

%

(8.4

)%

10.6

%

—

(3.3

)%

As Reported

As Recast

BSI BioSpin

BSI CALID

BSI NANO

BEST

Corporate

Total

BSI BIOS

BSI BMID

BSI NANO

BEST

Corporate

Total

Three months ended March 31, 2025

Revenue from external customers

$

207.8

$

280.1

$

256.6

$

56.9

—

$

801.4

$

368.9

$

119.0

$

256.6

$

56.9

—

$

801.4

Intersegment revenue

—

—

—

2.4

—

2.4

—

—

—

2.4

—

2.4

Total segment revenue

$

207.8

$

280.1

$

256.6

$

59.3

—

$

803.8

$

368.9

$

119.0

$

256.6

$

59.3

—

$

803.8

Gross profit

$

93.7

$

153.3

$

131.4

$

12.8

—

$

391.2

$

178.9

$

68.1

$

131.4

$

12.8

—

$

391.2

Gross profit margin

45.1

%

54.7

%

51.2

%

21.6

%

—

48.8

%

48.5

%

57.2

%

51.2

%

21.6

%

—

48.8

%

Operating income

$

23.7

$

40.2

$

(7.0

)

$

6.9

$

(32.0

)

$

31.8

$

40.5

$

23.4

$

(7.0

)

$

6.9

$

(32.0

)

$

31.8

Operating margin

11.4

%

14.4

%

(2.7

)%

11.6

%

—

4.0

%

11.0

%

19.7

%

(2.7

)%

11.6

%

—

4.0

%

Three months ended June 30, 2025

Revenue from external customers

$

195.3

$

285.8

$

252.1

$

64.2

—

$

797.4

$

357.0

$

124.1

$

252.1

$

64.2

—

$

797.4

Intersegment revenue

—

—

—

2.1

—

2.1

—

—

—

2.1

—

2.1

Total segment revenue

$

195.3

$

285.8

$

252.1

$

66.3

—

$

799.5

$

357.0

$

124.1

$

252.1

$

66.3

—

$

799.5

Gross profit

$

83.4

$

145.3

$

115.9

$

13.3

—

$

357.9

$

157.6

$

71.1

$

115.9

$

13.3

—

$

357.9

Gross profit margin

42.7

%

50.8

%

46.0

%

20.1

%

—

44.9

%

44.1

%

57.3

%

46.0

%

20.1

%

—

44.9

%

Operating income

$

18.1

$

26.2

$

(13.4

)

$

7.2

$

(26.2

)

$

11.9

$

18.3

$

26.0

$

(13.4

)

$

7.2

$

(26.2

)

$

11.9

Operating margin

9.3

%

9.2

%

(5.3

)%

10.9

%

—

1.5

%

5.1

%

21.0

%

(5.3

)%

10.9

%

—

1.5

%

Six months ended June 30, 2025

Revenue from external customers

$

403.1

$

565.9

$

508.7

$

121.1

—

$

1,598.8

$

725.9

$

243.1

$

508.7

$

121.1

—

$

1,598.8

Intersegment revenue

—

—

—

4.5

—

4.5

—

—

—

4.5

—

4.5

Total segment revenue

$

403.1

$

565.9

$

508.7

$

125.6

—

$

1,603.3

$

725.9

$

243.1

$

508.7

$

125.6

—

$

1,603.3

Gross profit

$

177.1

$

298.7

$

247.3

$

26.0

—

$

749.1

$

336.6

$

139.2

$

247.3

$

26.0

—

$

749.1

Gross profit margin

43.9

%

52.8

%

48.6

%

20.7

%

—

46.9

%

46.4

%

57.3

%

48.6

%

20.7

%

—

46.9

%

Operating income

$

41.7

$

66.4

$

(20.4

)

$

14.1

$

(58.1

)

$

43.7

$

58.7

$

49.4

$

(20.4

)

$

14.1

$

(58.1

)

$

43.7

Operating margin

10.3

%

11.7

%

(4.0

)%

11.2

%

—

2.7

%

8.1

%

20.3

%

(4.0

)%

11.2

%

—

2.7

%

As Reported

As Recast

BSI BioSpin

BSI CALID

BSI NANO

BEST

Corporate

Total

BSI BIOS

BSI BMID

BSI NANO

BEST

Corporate

Total

Three months ended September 30, 2025

Revenue from external customers

$

208.7

$

312.7

$

266.5

$

72.6

—

$

860.5

$

391.2

$

130.2

$

266.5

$

72.6

—

$

860.5

Intersegment revenue

—

—

—

1.2

—

1.2

—

—

—

1.2

—

1.2

Total segment revenue

$

208.7

$

312.7

$

266.5

$

73.8

—

$

861.7

$

391.2

$

130.2

$

266.5

$

73.8

—

$

861.7

Gross profit

$

90.4

$

159.0

$

118.4

$

11.6

—

$

379.4

$

172.9

$

76.5

$

118.4

$

11.6

—

$

379.4

Gross profit margin

43.3

%

50.8

%

44.4

%

15.7

%

—

44.1

%

44.2

%

58.8

%

44.4

%

15.7

%

—

44.1

%

Operating income

$

8.5

$

47.4

$

(72.2

)

$

4.6

$

(40.1

)

$

(51.8

)

$

24.6

$

31.3

$

(72.2

)

$

4.6

$

(40.1

)

$

(51.8

)

Operating margin

4.1

%

15.2

%

(27.1

)%

6.2

%

—

(6.0

)%

6.3

%

24.0

%

(27.1

)%

6.2

%

—

(6.0

)%

Nine months ended September 30, 2025

Revenue from external customers

$

611.8

$

878.6

$

775.2

$

193.7

—

$

2,459.3

$

1,117.1

$

373.3

$

775.2

$

193.7

—

$

2,459.3

Intersegment revenue

—

—

—

5.7

—

5.7

—

—

—

5.7

—

5.7

Total segment revenue

$

611.8

$

878.6

$

775.2

$

199.4

—

$

2,465.0

$

1,117.1

$

373.3

$

775.2

$

199.4

—

$

2,465.0

Gross profit

$

267.5

$

457.6

$

365.8

$

37.6

—

$

1,128.5

$

509.4

$

215.7

$

365.8

$

37.6

—

$

1,128.5

Gross profit margin

43.7

%

52.1

%

47.2

%

18.9

%

—

45.9

%

45.6

%

57.8

%

47.2

%

18.9

%

—

45.9

%

Operating income

$

50.2

$

113.8

$

(92.6

)

$

18.7

$

(98.2

)

$

(8.1

)

$

83.3

$

80.7

$

(92.6

)

$

18.7

$

(98.2

)

$

(8.1

)

Operating margin

8.2

%

13.0

%

(11.9

)%

9.4

%

—

(0.3

)%

7.5

%

21.6

%

(11.9

)%

9.4

%

—

(0.3

)%

As Reported

As Recast

BSI BioSpin

BSI CALID

BSI NANO

BEST

Corporate

Total

BSI BIOS

BSI BMID

BSI NANO

BEST

Corporate

Total

Fiscal year ended December 31, 2025

Revenue from external customers

$

878.8

$

1,210.2

$

1,084.3

$

263.2

—

$

3,436.5

$

1,580.1

$

508.9

$

1,084.3

$

263.2

—

$

3,436.5

Intersegment revenue

—

—

—

7.7

—

7.7

—

—

—

7.7

—

7.7

Total segment revenue

$

878.8

$

1,210.2

$

1,084.3

$

270.9

—

$

3,444.2

$

1,580.1

$

508.9

$

1,084.3

$

270.9

—

$

3,444.2

Gross profit

$

389.1

$

625.6

$

516.3

$

46.7

—

$

1,577.7

$

729.1

$

285.6

$

516.3

$

46.7

—

$

1,577.7

Gross profit margin

44.3

%

51.7

%

47.6

%

17.2

%

—

45.9

%

46.1

%

56.1

%

47.6

%

17.2

%

—

45.9

%

Operating income

$

104.3

$

153.3

$

(71.8

)

$

19.4

$

(137.0

)

$

68.2

$

168.8

$

88.8

$

(71.8

)

$

19.4

$

(137.0

)

$

68.2

Operating margin

11.9

%

12.7

%

(6.6

%)

7.2

%

—

2.0

%

10.7

%

17.4

%

(6.6

%)

7.2

%

—

2.0

%

Fiscal year ended December 31, 2024

Revenue from external customers

$

905.7

$

1,093.5

$

1,098.3

$

268.9

—

$

3,366.4

$

1,577.5

$

421.7

$

1,098.3

$

268.9

—

$

3,366.4

Intersegment revenue

—

—

—

14.1

—

14.1

—

—

—

14.1

—

14.1

Total segment revenue

$

905.7

$

1,093.5

$

1,098.3

$

283.0

—

$

3,380.5

$

1,577.5

$

421.7

$

1,098.3

$

283.0

—

$

3,380.5

Gross profit

$

453.9

$

593.9

$

540.4

$

61.3

—

$

1,649.5

$

803.2

$

244.6

$

540.4

$

61.3

—

$

1,649.5

Gross profit margin

50.1

%

54.3

%

49.2

%

21.7

%

—

49.0

%

50.9

%

58.0

%

49.2

%

21.7

%

—

49.0

%

Operating income

$

157.8

$

180.0

$

2.3

$

34.9

$

(121.9

)

$

253.1

$

235.9

$

101.9

$

2.3

$

34.9

$

(121.9

)

$

253.1

Operating margin

17.4

%

16.5

%

0.2

%

12.3

%

—

7.5

%

15.0

%

24.2

%

0.2

%

12.3

%

—

7.5

%

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 5

v3.26.3

Document and Entity Information

Nov. 05, 2026

Entity Listings [Line Items]

Entity Registrant Name

BRUKER CORPORATION

Amendment Flag

false

Entity Central Index Key

0001109354

Document Type

8-K

Document Period End Date

Nov. 05, 2026

Entity Incorporation State Country Code

DE

Entity File Number

000-30833

Entity Tax Identification Number

04-3110160

Entity Address, Address Line One

40 Manning Road

Entity Address, City or Town

Billerica

Entity Address, State or Province

MA

Entity Address, Postal Zip Code

01821

City Area Code

978

Local Phone Number

663-3660

Written Communications

false

Soliciting Material

false

Pre Commencement Tender Offer

false

Pre Commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Common Stock

Entity Listings [Line Items]

Security 12b Title

Common Stock, $0.01 par value per share

Trading Symbol

BRKR

Security Exchange Name

NASDAQ

6.375% Mandatory Convertible Preferred Stock, Series A

Entity Listings [Line Items]

Security 12b Title

6.375% Mandatory Convertible Preferred Stock, Series A, $0.01 par value per share

Trading Symbol

BRKRP

Security Exchange Name

NASDAQ

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_EntityListingsLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type:

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=brkr_SixPointThreeSevenFivePercentageMandatoryConvertiblePreferredStockSeriesAMember

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type: